KALA Price / Book | KALA BIO, INC.

KALA BIO, INC. (KALA) Price / Book

2026-09-03: Price/Book Ratio 1.19.
2026-06-30: Price/Book Ratio 3.7.
2026-03-31: Price/Book Ratio 14.94.
2025-12-31: Price/Book Ratio 2.21.

Historical market capitalization divided by filed shareholder equity.

Available history: 2017-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.19
2026-06-30	3.7
2026-03-31	14.94
2025-12-31	2.21
2025-03-31	323.86
2024-12-31	171.39
2024-09-30	191.56
2024-06-30	118.84
2024-03-31	168.5
2023-12-31	128.7
2023-09-30	106.78
2023-06-30	105.88
2023-03-31	74.07
2022-12-31	171.61
2021-12-31	238.07
2021-09-30	6,935.34
2021-06-30	10,184
2021-03-31	9,792.3
2020-12-31	9,986.66
2020-09-30	9,913.71
2020-06-30	11,376.81
2020-03-31	8,476.57
2019-12-31	11,211.63
2019-09-30	7,631.86
2019-06-30	8,849.99
2019-03-31	8,504.96
2018-12-31	3,943.46
2018-09-30	11,070.17
2018-06-30	12,396.72
2018-03-31	12,106.58
2017-12-31	12,648.26
2017-09-30	14,062.11

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
Theriva Biologics, Inc. (TOVX)	United States	$0.011B
Azitra, Inc. (AZTR)	United States	$0.010B	-0.81
Dare Bioscience, Inc. (DARE)	United States	$0.011B
Medicus Pharma Ltd. (MDCX)		$0.010B
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
Aprea Therapeutics, Inc. (APRE)	United States	$0.010B	-0.78
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92